NY Times
Lawmakers requested information on Thursday from regulators about Johnson & Johnson’s recall of Children’s Tylenol and other over-the-counter pediatric medicines, saying the company’s repeated recalls “point to a major problem” with production.
The House Committee on Oversight and Government Reform has opened an investigation after Johnson & Johnson recalled 40 widely used children’s pain and allergy medications, saying some might have a higher concentration of their active ingredients, while others might be contaminated.
In an F.D.A. report issued Tuesday, inspectors said they had found thick dust, grime and contaminated ingredients at the plant that produces Children’s Tylenol and dozens of other products recalled last week.
Johnson & Johnson has had four recalls of over-the-counter medicines in the last year.
“Taken together, these recalls point to a major problem in the production of McNeil products,” the committee chairman, Edolphus Towns, Democrat of New York, and the panel’s ranking Republican, Darrell E. Issa of California, said in a statement, referring to the company’s consumer health care unit.
The McNeil unit of Johnson & Johnson declined to comment.
The House Committee on Oversight and Government Reform has opened an investigation after Johnson & Johnson recalled 40 widely used children’s pain and allergy medications, saying some might have a higher concentration of their active ingredients, while others might be contaminated.
In an F.D.A. report issued Tuesday, inspectors said they had found thick dust, grime and contaminated ingredients at the plant that produces Children’s Tylenol and dozens of other products recalled last week.
Johnson & Johnson has had four recalls of over-the-counter medicines in the last year.
“Taken together, these recalls point to a major problem in the production of McNeil products,” the committee chairman, Edolphus Towns, Democrat of New York, and the panel’s ranking Republican, Darrell E. Issa of California, said in a statement, referring to the company’s consumer health care unit.
The McNeil unit of Johnson & Johnson declined to comment.
No comments:
Post a Comment